pre-ipo
Stage
About
ADAG is a clinical-stage immunotherapy and biopharmaceutical company developing targeted therapies, including antibody-drug conjugates, for cancer treatment.
Explore ADAG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.